128 related articles for article (PubMed ID: 38562766)
1. Antigen-driven CD8
Burtis AEC; DeNicola DMC; Ferguson ME; Santos RG; Pinilla C; Kriss MS; Orlicky DJ; Tamburini BAJ; Gillen AE; Burchill MA
bioRxiv; 2024 Mar; ():. PubMed ID: 38562766
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.
Grøndal SM; Tutusaus A; Boix L; Reig M; Blø M; Hodneland L; Gausdal G; Jackson A; Garcia de Frutos P; Lorens JB; Morales A; Marí M
Front Immunol; 2024; 15():1400553. PubMed ID: 38817615
[TBL] [Abstract][Full Text] [Related]
3. Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis.
Yashaswini CN; Qin T; Bhattacharya D; Amor C; Lowe S; Lujambio A; Wang S; Friedman SL
J Hepatol; 2024 Mar; ():. PubMed ID: 38508241
[TBL] [Abstract][Full Text] [Related]
4. Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module.
Bendixen SM; Jakobsgaard PR; Hansen D; Hejn KH; Terkelsen MK; Bjerre FA; Thulesen AP; Eriksen NG; Hallenborg P; Geng Y; Dam TV; Larsen FT; Wernberg CW; Vijayathurai J; Scott EAH; Marcher AB; Detlefsen S; Grøntved L; Dimke H; Berdeaux R; de Aguiar Vallim TQ; Olinga P; Lauridsen MM; Krag A; Blagoev B; Ravnskjaer K
J Hepatol; 2024 Mar; 80(3):467-481. PubMed ID: 37972658
[TBL] [Abstract][Full Text] [Related]
5. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA
Xie Y; Huang Y; Li ZY; Jiang W; Shi NX; Lu Y; Cao G; Yin Z; Lin XJ
Mol Cancer; 2024 May; 23(1):95. PubMed ID: 38720319
[TBL] [Abstract][Full Text] [Related]
7. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.
Provera A; Ramavath NN; Gadipudi LL; Gigliotti CL; Boggio E; Vecchio C; Stoppa I; Rolla R; Boldorini R; Pirisi M; Smirne C; Albano E; Dianzani U; Sutti S
Front Immunol; 2023; 14():1290391. PubMed ID: 38077334
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate Oxidation Sustains B Cell Antigen-Specific Activation to Exacerbate MASH.
Barrow F; Wang H; Fredrickson G; Florczak K; Ciske E; Khanal S; Parthiban P; Nguyen H; Rios E; Kostallari E; Revelo XS
bioRxiv; 2023 Nov; ():. PubMed ID: 38014163
[TBL] [Abstract][Full Text] [Related]
9. Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations.
Hunter S; Willcox CR; Davey MS; Kasatskaya SA; Jeffery HC; Chudakov DM; Oo YH; Willcox BE
J Hepatol; 2018 Sep; 69(3):654-665. PubMed ID: 29758330
[TBL] [Abstract][Full Text] [Related]
10. Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma.
Wen J; Zhang X; Wong CC; Zhang Y; Pan Y; Zhou Y; Cheung AH; Liu Y; Ji F; Kang X; Liu D; Yu J
Gut; 2024 May; ():. PubMed ID: 38744443
[TBL] [Abstract][Full Text] [Related]
11. Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.
Foglia B; Sutti S; Cannito S; Rosso C; Maggiora M; Casalino A; Bocca C; Novo E; Protopapa F; Ramavath NN; Provera A; Gambella A; Bugianesi E; Tacke F; Albano E; Parola M
Front Immunol; 2024; 15():1342404. PubMed ID: 38469298
[TBL] [Abstract][Full Text] [Related]
12. Τ cell-mediated adaptive immunity in the transition from metabolic dysfunction-associated steatohepatitis to hepatocellular carcinoma.
Papadopoulos G; Giannousi E; Avdi AP; Velliou RI; Nikolakopoulou P; Chatzigeorgiou A
Front Cell Dev Biol; 2024; 12():1343806. PubMed ID: 38774646
[TBL] [Abstract][Full Text] [Related]
13. Functional phenotyping of hepatic lymphocytes in murine MASH by mass cytometry.
Barrow F; Fredrickson G; Wang H; Revelo XS
STAR Protoc; 2023 Dec; 4(4):102743. PubMed ID: 37995192
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASH.
Navarro-Corcuera A; Zhu Y; Ma F; Gupta N; Asplund H; Yuan F; Friedman S; Sansbury BE; Huang X; Cai B
bioRxiv; 2024 Apr; ():. PubMed ID: 38712196
[TBL] [Abstract][Full Text] [Related]
15. Circulating Neutrophil Profiles Undergo a Dynamic Shift during Metabolic Dysfunction-Associated Steatohepatitis (MASH) Progression.
Maretti-Mira AC; Salomon MP; Chopra S; Yuan L; Golden-Mason L
Biomedicines; 2024 May; 12(5):. PubMed ID: 38791066
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of 15-PGDH enhances MASH-HCC development via fatty acid-induced T-cell exhaustion.
Hu X; Yasuda T; Yasuda-Yosihara N; Yonemura A; Umemoto T; Nakachi Y; Yamashita K; Semba T; Arima K; Uchihara T; Nishimura A; Bu L; Fu L; Wei F; Zhang J; Tong Y; Wang H; Iwamoto K; Fukuda T; Nakagawa H; Taniguchi K; Miyamoto Y; Baba H; Ishimoto T
JHEP Rep; 2023 Dec; 5(12):100892. PubMed ID: 37942226
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of LCN13 through FXR activation ameliorates hepatocellular lipid accumulation and inflammation.
Qin X; Tan Y; Ren W; Zhou W; Niu R; Liang L; Li J; Cao K; Wei G; Zhu X; Huang M
Int Immunopharmacol; 2024 Apr; 131():111812. PubMed ID: 38493698
[TBL] [Abstract][Full Text] [Related]
18. Egr2 drives the differentiation of Ly6C
Iwata A; Maruyama J; Natsuki S; Nishiyama A; Tamura T; Tanaka M; Shichino S; Seki T; Komai T; Okamura T; Fujio K; Tanaka M; Asano K
Commun Biol; 2024 Jun; 7(1):681. PubMed ID: 38831027
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis.
Babuta M; Morel C; de Carvalho Ribeiro M; Calenda C; Ortega-Ribera M; Thevkar Nagesh P; Copeland C; Zhuang Y; Wang Y; Cho Y; Joshi R; Brezani V; Hawryluk D; Datta AA; Mehta J; Nasser I; Szabo G
Gut; 2024 May; ():. PubMed ID: 38777573
[TBL] [Abstract][Full Text] [Related]
20. A novel A2a adenosine receptor inhibitor effectively mitigates hepatic fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model.
Park S; Hwang S; Sun J; Jeon KH; Sheen N; Shin S; Kim TH; Lee YS; Seo W; Ryu JS; Kwon Y
Int J Biol Sci; 2024; 20(5):1855-1870. PubMed ID: 38481815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
